Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes
Chey Loveday(Institute of Cancer Research), Amanda S. Bruce(Wessex Regional Genetics Laboratory), Elizabeth Bancroft(Royal Marsden NHS Foundation Trust), Jackie Cook(Sheffield Children's Hospital), Emma Poyastro-Pearson(Institute of Cancer Research), Zosia Miedzybrodzka(NHS Grampian), Cathryn Bardsley, Steven R. Brant(Rutgers, The State University of New Jersey), Rachel Belk(St George's Hospital), G. Bromilow(Institute of Cancer Research), Julian Adlard(Chapel Allerton Hospital), Madelaine Bartlett(Amherst College), Lynn Greenhalgh, Kent R. Bailey(Mayo Clinic), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Alice Garrett(Institute of Cancer Research), Sandra Hanks(Institute of Cancer Research), N. Bradshaw(Institute of Cancer Research), P. Morrison(Queen's University Belfast), Corinne Brooks(Institute of Cancer Research), Philip Law(Institute of Cancer Research), Lyndon Walker(Churchill Hospital), Glen Brice(St George's, University of London), Birgitta Bernhard(University of Zurich), Julian Barwell(London North West Healthcare NHS Trust), Fiona Lalloo(St Mary's Hospital), Ajith Kumar(Great Ormond Street Hospital), J. Berg(Guy's Hospital), Laura Baxter(University of Warwick), Laura Boyes(Birmingham Women's Hospital), Madiha Ahmed(Quaid-i-Azam University), Mark T. Rogers, Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Mary Porteous(University of Edinburgh), Fiona Douglas(University of Southern California), J. Paterson(Institut Gustave Roussy), D. Timothy Bishop(University of Leeds), C Brewer(Royal Devon and Exeter Hospital), Alex Henderson(Centre for Life), C J Chapman(Wellington Hospital), Angela F. Brady(Northwick Park Hospital), Gerhardt Attard(London Cancer), Desmond P.J. Barton(NIHR Biomedical Research Centre at The Royal Marsden and the ICR), A. Ardern-Jones(University of Southampton)
Cited by 17
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k